Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
28 January 2014 08:57
Researchers are now working with a biotechnology company to prepare the experimental drug for patient trials
An experimental drug that researchers say can virtually halt the spread of breast cancer has given fresh hope to sufferers of the disease.
Scientists from Cardiff University's European Cancer Stem Cell Research Institute have found that the chemical compound in question suppresses a gene called Bc13, which appears to play a critical role in metastasis.
They conducted computer simulations to work out how Bc13 functioned and then blocked it in tests on mice using a compound identified from a "virtual library" of chemicals.
The spread of tumours to vital organs such as the liver, brain and lungs is the chief reason why people die from cancer.
In the case of breast cancer, as many as 12,000 women in the UK develop a metastatic disease each year - often several years after their initial diagnosis.
"Despite great improvements in therapy of early stage breast cancer, the current therapeutic options for patients with late stage metastatic disease are limited," said Dr Richard Clarkson, who was part of the research team.
"There is therefore a clear unmet clinical need to identify new drugs to reverse or at least to slow down disease progression."
When mice with metastatic breast cancer were treated with the compound, the spread of tumours to the lungs and other parts of the body was dramatically reduced. In some cases, suppressing Bc13 meant the spread of cancer was halted by more than 80%.
Breast cancer is the most common cancer in the UK. It mostly affects women over the age of 50, although younger women, and in rare cases, men, can also develop the disease.
Sufferers holidaying overseas should remember to purchase adequate
breast cancer travel insurance before jetting off, just in case something unexpected happens.
Following the successful testing on groups of mice, the scientists are now working with a UK-based biotechnology company called Tiziana Pharmaceuticals to further develop the drug and eventually bring it to clinical trials.
28 March 2017
Researchers have highlighted a generation gap in treatment quality of leukaemia patients.
25 March 2017
Want to slow down the ageing process? A new drug claims to be able to do just that - and experts have suggested it could be on the market in three years.
24 March 2017
People who drink moderately are less likely to suffer a heart attack, according to a new study.
23 March 2017
Passengers on certain flights into the UK will no longer be able to carry laptops and tablets like iPads in their hand luggage.
22 March 2017
Mountaineers looking to scale the world's highest peak may need to shell out for a GPS device, according to Nepal's tourism chief.
21 March 2017
The effects of being in skyscrapers, at concerts or even walking on wobbly bridges could help scientists understand the experiences of dementia sufferers, researchers are claiming.
18 March 2017
A young actor has released pictures of a lump on her throat that turned out to be thyroid cancer, with hopes the image will raise awareness and alert others who may be suffering from the disease.
17 March 2017
A "promising treatment" for aggressive blood cancer needs more evidence of its effectiveness before NHS doctors will be able to prescribe, a watchdog is warning.
16 March 2017
Millions of Brits are opting for coach holidays over jet-setting and cruises, new research indicates.
15 March 2017
Thousands of flights to and from America's north east have been cancelled in preparation for a "life-threatening" storm poised to hit the country.
14 March 2017
Seniors who experience weight loss should not put it down to the normal ageing process, experts are warning.
11 March 2017
Gatwick Airport is insisting it is still a "credible and deliverable" expansion option, as the airport experienced its busiest ever February.